Introduction to pharmacokinetics

Fundamentals of Medicinal Chemistry, Edited by Gareth Thomas 

---

Tozer TN, Rowland M. Introduction to pharmacokinetics and pharmacodynamic the quantitative basis of drug therapy. Baltimore (MD) Lippincott Williams Wilkins 2006. 

Clark B, Smith DA. An Introduction to Pharmacokinetics. 2nd ed. Oxford Blackwell, 1986. 

Tozer, T. N., 8c Rowland, M. (2006). Introduction to Pharmacokinetics and Pharmacodynamics The Quantitative Basis of Drug Therapy. Philadelphia, PAj Lippincott Williams Wilkins. 

F. F. Farris, R.L. Dedrick, P.V. Allen and J.C. Smith, Physiological model for the pharmacokinetics of methyl mercury in the growing rat. Toxicol. Appl. Pharmacol., 119 (1993) 74—90. P. Franklin, An Introduction to Fourier Methods and the Laplace Transformation. Dover, New York, 1958. 

This short introduction to the terms used in pharmacokinetics is intended to provide a general overview of the subject. Those wishing to obtain a proper grounding in this important subject are recommended to consult a standard textbook of pharmacology. 

Following an introduction to the necessities of filtering and risk assessment of potential new drug molecules before entering lead optimization, the equally important aspects of pharmacokinetic (ADME) and safety (toxicity) profiling are covered in separate parts. 

Non-compartmental or model-independent approaches to pharmacokinetics Pharmacodynamics of drug action Pharmacokinetic-pharmacodynamic models INTRODUCTION... 

Pharmacokinetic processes govern the absorption, distribution, and elimination of drugs and are of great practical importance in the choice and administration of a particular drug for a particular patient, eg, a patient with impaired renal function. The following paragraphs provide a brief introduction to pharmacodynamics and pharmacokinetics. 

The first two sections of Chapter 5 give a practical introduction to dynamic models and their numerical solution. In addition to some classical methods, an efficient procedure is presented for solving systems of stiff differential equations frequently encountered in chemistry and biology. Sensitivity analysis of dynamic models and their reduction based on quasy-steady-state approximation are discussed. The second central problem of this chapter is estimating parameters in ordinary differential equations. An efficient short-cut method designed specifically for PC s is presented and applied to parameter estimation, numerical deconvolution and input determination. Application examples concern enzyme kinetics and pharmacokinetic compartmental modelling. 

The discussion above provides a brief qualitative introduction to the transport and fate of chemicals in the environment. The goal of most fate chemists and engineers is to translate this qualitative picture into a conceptual model and ultimately into a quantitative description that can be used to predict or reconstruct the fate of a chemical in the environment (Figure 27.1). This quantitative description usually takes the form of a mass balance model. The idea is to compartmentalize the environment into defined units (control volumes) and to write a mathematical expression for the mass balance within the compartment. As with pharmacokinetic models, transfer between compartments can be included as the complexity of the model increases. There is a great deal of subjectivity to assembling a mass balance model. However, each decision to include or exclude a process or compartment is based on one or more assumptions—most of which can be tested at some level. Over time the applicability of various assumptions for particular chemicals and environmental conditions become known and model standardization becomes possible. 

This chapter reviews the bioanalytical developments by mass spectrometry in the field of targeted anticancer therapy, across the growing family of recent FDA-approved oral TKIs as well as tamoxifen and its active metabolites. The text also provides an introduction to existing pharmacokinetics-pharmacodynamics knowledge in the field of targeted anticancer therapy. 

J.G. Wagner, Introduction to biopharmaceutics, Chapter 1, in Biopharmaceutics and Relevant Pharmacokinetics, J.G. Wagner, ed., Drug Intelligence Publications, pp. 1-5, 1971. 

To date, several excellent review articles have been published on the prediction of various pharmacokinetic parameters. Consequently, it is not intended that this chapter will provide a full review of the current literature in this area. This chapter provides an introduction to key pharmacokinetic parameters and an overview of references concerning their prediction. A discussion of how the data, available from diverse sources, can be structured and used to address specific questions in pharmacokinetics and toxicokinetics will then be presented. 

Matis, J., An introduction to stochastic compartmental models in pharmacokinetics, Pharmacokinetics-Mathematical and Statistical Approaches in Metabolism and Distribution of Chemicals and Drugs, edited by A. Pecile and A. Rescigno, Plenum Press, New York, 1988, pp. 113-128. 

Although somewhat overly simplistic (especially to readers who are students of pharmacy) we can consider pharmacokinetic effects as "what the body does to the drug" and pharmacodynamic effects as "what the drug does to the body." For those readers who are less familiar with pharmacokinetics and pharmacodynamics, Tozer and Roland (2006) provide an excellent and very readable introduction to these topics. 

SMITH, D.A. (1997) Pharmacokinetics and pharmacodynamics in toxicology. Xenobiotica 27, 513. YANG, R.S.H. and ANDERSEN, M.E. (1994) Pharmacokinetics. In Introduction to Biochemical Toxicology, edited by E.Hodgson and P.E.Levi, 2nd edition (Connecticut Appleton-Lange). ZBINDEN, G. (1988) Biopharmaceutical studies, a key to better toxicology. Xenobiotica, 18, Suppl. 1,9. 

After an introduction to basic principles, the book is divided into sections that cover industrial and regulatory applications, clinical applications, and research applications. A panel of experts provide extensive background for each subspeciality. Covering the many subdisciplines and providing pharmacokinetic concepts, terminology, and approaches. Pharmacokinetics in Drug Discovery and Development serves as a resource for professionals throughout this field. 

As listed in the table of contents, the book is organized into 19 chapters, the last one appearing as an Appendix. The first chapter consists of an introduction to the principles necessary to understand pharmacokinetics as well as an overview of the subject matter. The remaining chapters are organized in an order that should be easy for the reader to follow, while still demonstrating the salient features of each topic. Clearance and other essential fundamental pharmacokinetic parameters have been introduced early in the book, since the student will need to apply these concepts in subsequent chapters. This has necessitated cross referencing concepts introduced in the first few chapters throughout the remainder of the book. 

---